Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
CTLT

CTLT - Catalent Inc Stock Price, Fair Value and News

$63.48 
Market Closed

Price Targets

CTLT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CTLT Price Action

CTLT RSI Chart

CTLT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CTLT Valuation

CTLT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

CTLT Fundamentals

CTLT Revenue

CTLT Earnings

Earnings (TTM)

-224.0M

CTLT Profitability

Return on Equity

-4.69%

Return on Assets

-2.13%

CTLT Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20244.1B4.4B4.4B0
20234.5B4.3B4.2B4.1B
20224.7B4.8B4.8B4.7B
20215.9B4.0B4.2B4.5B
20202.9B5.2B5.4B5.6B
20192.5B2.5B2.6B2.7B
20182.4B2.5B2.5B2.5B
20172.0B2.1B2.2B2.3B
20161.8B1.8B1.9B1.9B
20151.8B1.8B1.8B1.8B
20141.8B1.8B1.8B1.8B
20131.8B1.8B1.8B1.8B
201201.7B1.7B1.7B
Get all data in R, Python etc through our Historical Stock Data APIs

About Catalent Inc

CTLT
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.
 CEO
 WEBSITEcatalent.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES17800

Catalent Inc Frequently Asked Questions

CTLT is the stock ticker symbol of Catalent Inc. Every public company that trades on a stock exchange gets a ticker symbol.

You can check CTLT's fair value in chart for subscribers.

The fair value guage provides a quick view whether CTLT is over valued or under valued. Whether Catalent Inc is cheap or expensive depends on the assumptions which impact Catalent Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CTLT.